CIRCULOGENE is a top-tier biotech company based in Birmingham, AL, with a mission to revolutionize cancer detection through liquid biopsy. With expertise in bioinformatics, next-generation sequencing, and polymerase chain reaction, CIRCULOGENE offers advanced liquid biopsy services that provide high sensitivity detection across various samples. By leveraging proven technology, CIRCULOGENE delivers noninvasive and cost-effective solutions for personalized therapy based on patients' molecular fingerprints or tumor profiles.

Their unique methodologies in sample preparation ensures fragile cfRNA is extracted and preserved, while combining NGS and PCR technologies enhances the discovery of actionable markers, mutations, and fusions. CIRCULOGENE also offers specialized tests such as the only plasma cfRNA PD-L1 test for non-small cell lung cancer patients treated with immunotherapy and MSI Complete for colorectal cancer patients. With a team of experienced professionals and state-of-the-art laboratory equipment, CIRCULOGENE is at the forefront of liquid biopsy advancements, transforming cancer into a manageable disease.

Contact them today for the best-in-class treatment options for every patient